Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
42,069,711
-
Share change
-
-12,604,929
-
Total reported value
-
$75,701,107
-
Put/Call ratio
-
95%
-
Price per share
-
$1.80
-
Number of holders
-
101
-
Value change
-
-$23,572,653
-
Number of buys
-
31
-
Number of sells
-
91
Institutional Holders of CLOVIS ONCOLOGY INC - COM (CLVSQ) as of Q2 2022
As of 30 Jun 2022,
CLOVIS ONCOLOGY INC - COM (CLVSQ) was held by
101 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
42,069,711 shares.
The largest 10 holders included
VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., Palo Alto Investors LP, RENAISSANCE TECHNOLOGIES LLC, QVT Financial LP, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Ergoteles LLC, and PINNACLE ASSOCIATES LTD.
This page lists
101
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.